Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Sep;89(9):1359-64.
doi: 10.2105/ajph.89.9.1359.

The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools

Affiliations

The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools

G B LeFever et al. Am J Public Health. 1999 Sep.

Abstract

Objectives: The purpose of this study was to determine the extent of medication use for attention deficit-hyperactivity disorder (ADHD) in southeastern Virginia.

Methods: Students enrolled in grades 2 through 5 in school districts in city A (n = 5767 students) and city B (n = 23,967 students) were included. Nurses recorded students who received ADHD medication in school.

Results: The proportion of students receiving ADHD medication was similar in both cities (8% and 10%) and was 2 to 3 times as high as the expected rate of ADHD. Receipt of drug therapy was associated with social and educational characteristics. Medication was used by 3 times as many boys as girls and by twice as many Whites as Blacks. Medication use increased with years in school, and by fifth grade 18% to 20% of White boys were receiving ADHD medication. Being young for one's grade was positively associated with medication use (P < .01). The prevalence of ADHD was 12% in district A, 63% in district B.

Conclusions: These findings suggest that criteria for diagnosis of ADHD vary substantially across US populations, with potential overdiagnosis and overtreatment of ADHD in some groups of children.

PubMed Disclaimer

References

    1. J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1514-24 - PubMed
    1. N Engl J Med. 1995 Oct 5;333(14):944 - PubMed
    1. Pediatrics. 1996 Dec;98(6 Pt 1):1084-8 - PubMed
    1. Psychopharmacol Bull. 1997;33(1):143-7 - PubMed
    1. J Child Adolesc Psychopharmacol. 1996 Fall;6(3):165-75 - PubMed

MeSH terms